Literature DB >> 847207

Comparative evaluation of 99mTc GH, 99mTcO4, and 99mTc DTPA as brain imaging agents.

F D Rollo, R R Cavalieri, M Born, L Blei, M Chew.   

Abstract

The brain imaging properties of 99mTc glucoheptonate, 99mTc pertechnetate, and 99mTc DPTA are compared. Results demonstrate that optimum images are obtained at 90, 180, and 180 min., for 99mTc GH, 99mTc DTPA, and 99mTc perterchnetate, respectively. The former two images are not affected by prior bone imaging with 99mTc pyrophosphate, while 99mTc pertechnetate images are adversely affected. 99mTc glucoheptonate appears to be the superior agent for brain imaging, followed by 99mTc DTPA and 99mTc pertechnetate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 847207     DOI: 10.1148/123.2.379

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Brain scintigraphy with 99mTc-citrate and 99mTc-DTPA: a clinical comparison of the results.

Authors:  A Castagnoli; A Pupi; G Guizzardi; P Ferri; N Taverni; U Meldolesi; A Formiconi
Journal:  Eur J Nucl Med       Date:  1982

Review 2.  Use of 99m-technetium-glucoheptonate as a tracer for brain tumor imaging: An overview of its strengths and pitfalls.

Authors:  Amburanjan Santra; Rakesh Kumar; Punit Sharma
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.